Profile
Ken-ichiro Hata currently works at Forum For Innovative Regenerative Medicine, as Chairman from 2019 and Cellular Dynamics International Japan Co., Ltd., as Director from 2017.
Dr. Hata also formerly worked at Japan Tissue Engineering Co., Ltd., as Chairman & Executive Officer from 2019 to 2020 and FUJIFILM Corp., as Deputy Manager-Bioscience & Technology Development from 2018 to 2020.
Ken-ichiro Hata active positions
| Companies | Position | Start |
|---|---|---|
Cellular Dynamics International Japan Co., Ltd.
Cellular Dynamics International Japan Co., Ltd. BiotechnologyHealth Technology Manufactures biological products | Director/Board Member | 2017-06-30 |
Forum For Innovative Regenerative Medicine | Chairman | 2019-05-31 |
Former positions of Ken-ichiro Hata
| Companies | Position | End |
|---|---|---|
FUJIFILM Corp.
FUJIFILM Corp. Electronics/AppliancesConsumer Durables Manufactures and markets photographic equipment & supplies, medical systems, life science products and pharmaceuticals | Chief Tech/Sci/R&D Officer | 2018-02-28 |
| JAPAN TISSUE ENGINEERING CO., LTD. | Chairman | 2020-06-24 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. Medical/Nursing ServicesHealth Services Develops, manufactures and sells tissue-engineered medical products | Health Services |
FUJIFILM Corp.
FUJIFILM Corp. Electronics/AppliancesConsumer Durables Manufactures and markets photographic equipment & supplies, medical systems, life science products and pharmaceuticals | Consumer Durables |
Forum For Innovative Regenerative Medicine | |
Cellular Dynamics International Japan Co., Ltd.
Cellular Dynamics International Japan Co., Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
- Stock Market
- Insiders
- Ken-ichiro Hata
















